If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
198.00    -15.00 (-7.04%)
Bid:
196.50
Ask:
204.00
Spread: 7.50 (3.817%)
Market Cap: £105.97m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Director/PDMR Shareholding

16 Mar 2017 16:31

RNS Number : 7386Z
Microgen PLC
16 March 2017
 

16 March 2017

 

MICROGEN plc (the "Company")

 

Director/PDMR Shareholding / Total Voting Rights

 

Microgen plc (LSE: MCGN), a leading provider of business critical software and services, provides notification that on 16 March 2017, following the exercise by a number of the Company's Executive Directors of options under the Microgen Plc Performance Share Plan 2006 ("PSP"), 780,618 new ordinary shares of 6 3/7 pence each in the Company ("Ordinary Shares") have been issued. The issued Ordinary Shares were admitted to the Official List of the UKLA and to trading on the main market of the London Stock Exchange on 25 November 2016.

 

Each of the Executive Directors named below exercised options over the number of Ordinary Shares specified below on 16 March 2017 with an exercise price per Ordinary Share of £0.05. The options had an expiry date of 18 November 2023.

 

Following the exercise of these options each Executive Director's overall shareholding in the Company has increased as set out in the following table. Each Executive Director also sold a number of the resulting Ordinary Shares on 16 March 2017 at a price of £2.70 per Ordinary Share, as set out below.

 

Name of Executive Director

No. of Options Exercised

No. of Ordinary Shares sold

No. of Ordinary Shares held prior to transactions

Number of Ordinary Shares held after transactions

 

Percentage of the issued share capital of the Company held prior to transactions

Percentage of the issued share capital of the Company held after transactions

Tom Crawford (CEO, Aptitude Software)

140,206

69,757

309,551

380,000

0.52%

0.63%

Simon Baines (CEO, Microgen Financial Systems)

320,206

229,729

9,523

100,000

0.02%

0.16%

Philip Wood (Chief Financial Officer)

320,206

230,841

110,635

200,000

0.18%

0.33%

 

In accordance with DTR 5.6.1, the Company also announces that, following the transactions referred to above, as at today's date, its issued share capital comprises 60,771,938 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. The voting rights of all of the Ordinary Shares are identical. Shareholders may use this figure as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Ordinary Shares in Microgen under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

The notification below, made pursuant to Article 19 of Regulation (EU) No 596/2014 on Market Abuse, provides further information about these transactions.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

(a)

Name

(i) Tom Crawford

(ii) Simon Baines

(iii) Philip Wood

 

2

Reason for the notification

 

(a)

Position/Status

(i) PDMR - (Chief Executive Officer, Aptitude Software)

(ii) PDMR - (Chief Executive Officer, Microgen Financial Systems)

(iii) PDMR - (Chief Financial Officer)

 

(b)

Initial notification / Amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

Microgen Plc

 

(b)

LEI

2138009VHA1WI2VKMA28

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary Shares of 6 3/7 pence each

 

 

ISIN: GB00BVVHWX30

(b)

Nature of the transaction

 

(a) Exercise of options over Ordinary Shares

(b) Sale of Ordinary Shares

 

(c)

Price(s) and volume(s)

 

Name

(a) Exercise Price per Ordinary Share

(a) Number of Ordinary Shares over which Options Exercised

(b) Sale Price per Ordinary Share

(b) Number of Ordinary Shares sold

(i) Tom Crawford

£0.05

140,206

£2.70

69,757

(ii) Simon Baines

£0.05

320,206

£2.70

229,729

(iii) Philip Wood

£0.05

320,206

£2.70

230,841

(d)

Aggregated Information

- Aggregated Volume

- Price

n/a

(e)

Date of the Transaction

16 March 2017

 

(f)

Place of the Transaction

(a) Outside a trading venue

(b) London Stock Exchange (XLON)

 

Name of authorised official of issuer responsible for making notification:

Mark Heather, Company Secretary, Microgen Plc

 

Contacts

Mark Heather, Company Secretary 020-7496-8100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUMPWUPMGQQ
Date   Source Headline
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSGrant of awards under 2016 Performance Share Plan
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 202411:40 amRNSTotal Voting Rights
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 202410:07 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSInterim Results
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTrading Update and Notice of Results
12th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSFynapse contract win with major existing client
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSNotification of Major Holdings
18th Jun 20247:00 amRNSFynapse Investor Insights Session
17th Jun 20247:00 amRNSFynapse contract win in partnership with HSO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.